The Effects of Statin Therapy on Mean Platelet Volume in Patients with Cardiovascular Diseases

Authors

  • Alaa Abduljabbar Abdulrazzaq Plant Biotechnology Department, Biotechnology College, Al-Nahrain University, IRAQ.
  • Rowshen Hani Plant Biotechnology, Biotechnology College, Al-Nahrain University, IRAQ.
  • Aya Raad Saleh Molecular And Medical Biotechnology Department, Biotechnology College, Al-Nahrain University, IRAQ.

DOI:

https://doi.org/10.55544/sjmars.3.6.6

Keywords:

Mean platelets volume (MPV), statin, flow cytometer, cardiovascular disease

Abstract

The statins are the excellent therapy for decreasing the lipid and described in about all patients with cardiovascular diseases. It has a strong role in decreasing the morbidity and mortality present with cardiovascular diseases. In recent study, it has been conducted that its major effects is far more than lowering the lipid but also it has a great role in cardiac diseases as the thrombocytopenia and platelet dysregulation also associated in decreasing the cardiac disease effects. This study explained the statin role on the efficiency of the markers and its effect in patients with cardiovascular disease. The platelet counts were examined by the flow cytometer, the samples of blood were collected from patients before and after treatment. The results showed the express of CD62P and CD63 were decrease in patients had the therapy compared to the patients without it. The study concluded that the statin therapy decrease the mean of platelet volume (MPV) in the patients suffer from this diseases.

References

[1] Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012; 366:1959–1967

[2] De Berardis G, Lucisano G, D’Ettorre A, Pellegrini F, Lepore V, Tognoni G, Nicolucci A. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA. 2012; 307:2286–2294.

[3] Schulman, S.; Kearon, C.; Kakkar, A.K.; Schellong, S.; Eriksson, H.; Baanstra, D.; Kvamme, A.M.; Friedman, J.; Mismetti, P.; Goldhaber, S.Z. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N. Engl. J. Med. 2013, 368, 709–718

[4] Kucera M, Balaz D, Kruzliak P, Ciccocioppo R, Oravec S, Rodrigo L, Zulli A, Hirnerova E, Sabaka P, Komornikov A, Sabo J, Slezak P, Gaspar L. (2015) The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators-A pilot study. Clin. Biochem. 48(9): 557-561.

[5] Gungoren F, Besli F, Caliskan S, Polat U, Basar C, Serda OA. (2015) Statin Therapy May not Effect NLR and MPV Levels in Patients with Hypercholesterolemia. Angiology 67(6): 536-540

[6] Erdim I, Oghan F. (2017) Blood count values and ratios for predicting sleep apnea in obese children. Int J Pediatr Otorhinolaryngol. 98:85.

[7] Diamantis E, Kyriakos G, Quiles-Sanchez LV et al (2017) The anti-infammatory efects of statins on coronary artery disease: an updated review of the literature. Curr Cardiol Rev 13(3):209–216

[8] GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYS) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the global burden of disease study. Lancet 388:1603–1658

[9] Ni R, Peleg T, Gross PL. (2012) Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase. Arterioscler Thromb Vasc Biol. 32(11):2609-2615. doi: 10.1161/ATVBAHA.112.300090

[10] Zhou Z, Chen H, Sun M, Ju H. (2018) Mean Platelet Volume and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. J Diabetes Res. 2018:1985026. doi: 10.1155/2018/1985026.

[11] Butt NF, Rathore R, Latif H, Mehmood H, Faisal HS, Iqbal A. (2018) Effect of atorvastatin on hematological parameters in patients with dyslipidemias. Pak. J. Med. Health Sci 12(3): 1087-1090.

[12] Chalubinski M, Broncel M. The influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in the treatment of auto-immune disorders. Med Sci Monit. 2010; 16:11.

[13] Jagroop IA, Persaud JW, Mikhailidis DP. A new rapid method to measure human platelet cholesterol: a pilot dtudy. Clin Appl Thromb Hemost. 2011; 17:578–84.

[14] de Jonge S, de Vos RJ, Weir A, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011

[15] Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med. 2014;42(3):610–618. doi:10.1177/0363546513518416

[16] Sundström J, Hedberg J, Thuresson M, Aarskog P, Johannesen KM, Oldgren J. Low-dose aspirin discontinuation and risk of cardiovascular events: a Swedish nationwide, population-based cohort study. Circulation. 2017;136(13):1183–1192. doi:10.1161/CIRCULATIONAHA.117.028321

[17] Ghuman J, Manasewitsch NT, Ghuman J, Antwi-Amoabeng D, Chahal G: Atorvastatin-induced refractory thrombocytopenia. Cureus. 2021, 13:e12502. 10.7759/cureus.12502

[18] Murayama H, Sakuma M, Takahashi Y, Morimoto T: Improving the assessment of adverse drug reactions using the Naranjo algorithm in daily practice: the Japan Adverse Drug Events Study. Pharmacol Res Perspect. 2018, 6:e00373. 10.1002/prp2.373

[19] Sundstro ¨m J, Hedberg J, Thuresson M, Aarskog P, Johannesen KM, Oldgren J. Low-dose aspirin discontinuation and risk of cardiovascular events: a Swedish nationwide, population-based cohort study. Circulation. 2017; 136(13):1183-1192. doi:10.1161/CIRCULATIONAHA.117.028321

[20] Kuffler DP. Variables affecting the potential efficacy of PRP in providing chronic pain relief. JPainRes. 2018; 12:109-116. doi:10.2147/ JPR.S190065

[21] Zhang S, Rahman M, Zhang S, Qi Z, Thorlacius H. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis. J Leukoc Biol. 2011; 89: 735-742.

[22] Molins B, Pena E, Padro T, Casani L, Mendieta C, Badimon L. Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin. Arterioscler Thromb Vasc Biol. 2010; 30: 1246-1252.

[23] Lee YM, Chen WF, Chou DS, Jayakumar T, Hou SY, Lee JJ, et al. Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation. J Biomed Sci. 2010; 17: 45.

Downloads

Published

2025-01-06

How to Cite

Abduljabbar Abdulrazzaq, A., Hani, R., & Raad Saleh, A. (2025). The Effects of Statin Therapy on Mean Platelet Volume in Patients with Cardiovascular Diseases. Stallion Journal for Multidisciplinary Associated Research Studies, 3(6), 100–103. https://doi.org/10.55544/sjmars.3.6.6

Issue

Vol. 3 No. 6 (2024): December Issue

Section

Articles

License

Copyright (c) 2024 Stallion Journal for Multidisciplinary Associated Research Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.